Butanedione → HCID 22036570, compound
Reaction equation
[N:1]1([CH2:6][CH2:7][N:8]2[C:16]3[C:11](=[CH:12][C:13]([NH2:17])=[CH:14][CH:15]=3)[CH:10]=[N:9]2)[CH2:5][CH2:4][CH2:3][CH2:2]1.CC(=O)[C:20](C)=[O:21].[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+].[CH2:38]1[CH2:42][O:41][CH2:40]C1>CC(OC)(C)C>[CH3:20][O:21][CH:42]([O:41][CH3:40])[CH2:38][NH:17][C:13]1[CH:12]=[C:11]2[C:16](=[CH:15][CH:14]=1)[N:8]([CH2:7][CH2:6][N:1]1[CH2:5][CH2:4][CH2:3][CH2:2]1)[N:9]=[CH:10]2Participants
Procedure
To a solution of 1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-5-ylamine (1.14 g, 0.497 mmol) in 62 mL of dry THF was added 2.04 mL of dimethyl glyoxal in MTBE (45% glyoxal by weight). A slurry of NaBH(OAc)3 (1.66 g, 7.83 mmol) in THF (10 mL) was slowly added via addition funnel over 60 minutes, and the mixture stirred at room temperature. After 12 hours, an additional equivalent of NaBH(OAc)3 was added. After an additional 12 hours, the mixture was quenched with saturated. NaHCO3, filtered, and the solvents removed under reduced pressure. The residue was purified via column chromatography eluting with 5–15% Et3N in EtOAc to provide 650 mg (2.04 mmol) of the title compound. 1H NMR (300 MHz, DMSO-D6) δ ppm 1.50–1.74 (m, 4 H) 2.33–2.46 (m, 4 H) 2.81 (t, J=6.78 Hz, 2 H) 3.14 (t, J=5.76 Hz, 2 H) 3.33 (t, 6 H) 4.38 (t, J=6.78 Hz, 2 H) 4.54 (t, J=5.42 Hz, 1 H) 5.26 (t, J=6.10 Hz, 1 H) 6.63–6.73 (m, J=2.03 Hz, 1 H) 6.91 (dd, J=8.98, 2.20 Hz, 1 H) 7.28–7.46 (m, J=8.81 Hz, 1 H) 7.64–7.78 (m, 1 H); MS (ESI) m/z 319 [M+H]+.
Workup
- waitAfter an additional 12 hours
- customthe mixture was quenched with saturated
- filtrationNaHCO3, filtered
- customthe solvents removed under reduced pressure
- customThe residue was purified via column chromatography
- washeluting with 5–15% Et3N in EtOAc
Sources & evidence
- ORD record
- ord-4aea544eff374c7797839e5e5d48937d
- Source dataset
- uspto-grants-2006_07
- Patent number
- US07071182B2
Reaction notes
Loading…